Pathway Financial Advisers’s National Health Investors NHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-87
Closed -$6.03K 327
2024
Q4
$6.03K Buy
87
+1
+1% +$76 ﹤0.01% 388
2024
Q3
$7.23K Buy
86
+1
+1% +$77 ﹤0.01% 314
2024
Q2
$5.75K Buy
85
+2
+2% +$128 ﹤0.01% 380
2024
Q1
$5.26K Buy
83
+1
+1% +$56 ﹤0.01% 394
2023
Q4
$4.6K Buy
82
+1
+1% +$53 ﹤0.01% 418
2023
Q3
$4.16K Buy
+81
New +$4.24K ﹤0.01% 426
2023
Q1
$6.09K Sell
118
-68
-37% -$3.71K ﹤0.01% 427
2022
Q4
$9.72K Buy
+186
New +$10.2K ﹤0.01% 429

Other funds holding NHI

Pathway Financial Advisers's NHI Position: Q1 2025 in Review

Pathway Financial Advisers sold out of National Health Investors (NHI) in Q1 2025, closing a stake of 87 shares — an estimated $6.03K sold.

Pathway Financial Advisers first reported a position in NHI in Q4 2022 and held it in 8 quarters. The position peaked at $9.72K in Q4 2022. 285 funds tracked by Wall St. Rank hold NHI as of Q1 2025.

  • Pathway Financial Advisers reported no remaining National Health Investors position as of Q1 2025 after selling out during the quarter.
  • Pathway Financial Advisers sold 87 National Health Investors shares in Q1 2025, an estimated $6.03K.
  • Pathway Financial Advisers first reported a position in National Health Investors in Q4 2022 and held it in 8 quarters.
  • Pathway Financial Advisers's National Health Investors position peaked at $9.72K in Q4 2022.
  • 285 funds tracked by Wall St. Rank held National Health Investors as of Q1 2025.

Based on Pathway Financial Advisers's 13F filing for Q1 2025, filed 9 May 2025.